Literature DB >> 21249711

Sperm washing to prevent HIV transmission from HIV-infected men but allowing conception in sero-discordant couples.

Ahizechukwu C Eke1, Chikelue Oragwu.   

Abstract

BACKGROUND: Sperm washing is a term used to describe the process in which individual spermatozoa are separated from the seminal fluid. Sperm washing is used to prevent HIV transmission but allow conception in sero-discordant couples, where the male is HIV positive, but the female is HIV negative. This procedure is based on the observation that HIV cannot attach itself to spermatozoa, but it can be found in the fluid and cells surrounding spermatozoa.
OBJECTIVES: To determine the benefits and harms of sperm washing of HIV-infected males when used to prevent the transmission of HIV but allowing conception in the HIV-negative female. SEARCH STRATEGY: We searched the Cochrane HIV/AIDS Group Controlled Trials Register, the Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, SCORPUS, AIDsearch, AJOL, LILACS and INDEX MEDICUS. We also searched the following conference proceedings for relevant abstracts:The International AIDS Conference; The Conference on Retroviruses and Opportunistic Infections (CROI); The British HIV Association (BHIVA) Conference; The International Conference of Obstetricians and Gynecologists (FIGO); The American Academy of HIV Medicine Conference; The Australasian HIV/AIDS Conference; The American Society for Reproductive Medicine (ASRM) conferences and website; The European Society for Human Reproduction and Embryology (ESHRE) conferences and websites, and the British Fertility Society (BFS) conferences and website. We also conducted a search of the website: www.ClinicalTrials.gov. The date of the most recent Cochrane HIV/AIDS Group Controlled Trials Register search was on the 10th of November, 2010. SELECTION CRITERIA: We preferentially looked for randomised or quasi-randomised controlled trials on sperm washing, aimed at preventing HIV transmission from HIV infected men but allowing conception in sero-discordant couples, irrespective of publication status, year of publication, or language in the review. DATA COLLECTION AND ANALYSIS: No relevant trials were identified for inclusion in this review. MAIN
RESULTS: Forty four studies were identified, but none of them were suitable for inclusion in this review. AUTHORS'
CONCLUSIONS: Reports on the use of sperm washing to prevent HIV transmission from HIV infected men but allowing conception in sero-discordant couples is currently limited to observational studies. No randomised controlled trial has assessed the benefit or risk of sperm washing to prevent HIV transmission from HIV infected men but allow conception in sero-discordant couples. Thus, this systematic review identifies the need for a multicentre randomised controlled trial assessing the benefits and possible risks of sperm washing in preventing HIV transmission from HIV infected men but allow conception in sero-discordant couples.

Entities:  

Mesh:

Year:  2011        PMID: 21249711     DOI: 10.1002/14651858.CD008498.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  11 in total

Review 1.  Antiretrovirals and safer conception for HIV-serodiscordant couples.

Authors:  Lynn T Matthews; Jennifer A Smit; Susan Cu-Uvin; Deborah Cohan
Journal:  Curr Opin HIV AIDS       Date:  2012-11       Impact factor: 4.283

Review 2.  Gonadal function and reproductive health in women with human immunodeficiency virus infection.

Authors:  Swaytha Yalamanchi; Adrian Dobs; Ruth M Greenblatt
Journal:  Endocrinol Metab Clin North Am       Date:  2014-09       Impact factor: 4.741

Review 3.  Effectiveness of semen washing to prevent human immunodeficiency virus (HIV) transmission and assist pregnancy in HIV-discordant couples: a systematic review and meta-analysis.

Authors:  Maryam Zafer; Hacsi Horvath; Okeoma Mmeje; Sheryl van der Poel; Augusto E Semprini; George Rutherford; Joelle Brown
Journal:  Fertil Steril       Date:  2015-12-11       Impact factor: 7.329

Review 4.  ART in South Africa: The price to pay.

Authors:  C Huyser; L Boyd
Journal:  Facts Views Vis Obgyn       Date:  2013

Review 5.  Lights and Shadows about the Effectiveness of IVF in HIV Infected Women: A Systematic Review.

Authors:  Catarina Marques; Cristina Guerreiro; Sérgio Reis Soares
Journal:  Infect Dis Obstet Gynecol       Date:  2015-12-08

6.  Safer Conception Strategies for HIV-Serodiscordant Couples: How Safe Is Safe Enough?

Authors:  Andrea L Ciaranello; Lynn T Matthews
Journal:  J Infect Dis       Date:  2015-06-19       Impact factor: 5.226

7.  Characterization and distribution of HIV-infected cells in semen.

Authors:  Lin Gao; Yan-Mei Jiao; Ping Ma; Lijun Sun; Hongxin Zhao; An-Liang Guo; Xing Fan; Chao Zhang; Jin-Wen Song; Ji-Yuan Zhang; Fengmin Lu; Fu-Sheng Wang
Journal:  Emerg Microbes Infect       Date:  2022-12       Impact factor: 19.568

8.  Client and Provider Experiences in Uganda Suggest Demand for and Highlight the Importance of Addressing HIV Stigma and Gender Norms Within Safer Conception Care.

Authors:  Cynthia R Young; Elizabeth Gill; Mwebesa Bwana; Winnie Muyindike; Rebecca S Hock; Madeline C Pratt; Moran Owembabazi; Deogratius Tukwasibwe; Alice Najjuma; Paul Kalyebara; Silvia Natukunda; Angela Kaida; Lynn T Matthews
Journal:  AIDS Behav       Date:  2021-06-21

9.  Assisted reproductive technology and obstetric outcome in couples when the male partner has a chronic viral disease.

Authors:  Irene Molina; María Carmen Del Gonzalvo; Ana Clavero; Miguel Angel López-Ruz; Juan Mozas; Juan Pasquau; Antonio Sampedro; Luis Martínez; José Antonio Castilla
Journal:  Int J Fertil Steril       Date:  2013-12-22

10.  Nanoparticle incorporation of melittin reduces sperm and vaginal epithelium cytotoxicity.

Authors:  Andrew P Jallouk; Kelle H Moley; Kenan Omurtag; Grace Hu; Gregory M Lanza; Samuel A Wickline; Joshua L Hood
Journal:  PLoS One       Date:  2014-04-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.